The Global Patient Registry Software Market was valued at $1089.32 million in 2022, and is projected to reach $2,508.27 million by 2030, growing at a CAGR of 9.7% from 2023 to 2030| Data By Contrive Datum Insights Pvt Ltd.

According to a market research study published by Contrive Datum Insights, A patient register is a list of details about people who have the same illness or condition. Software for registering patients can be used to keep track of data and study the best ways to care for or help patients. Patient records are becoming more and more important in the healthcare system.


Farmington, April 24, 2023 (GLOBE NEWSWIRE) -- The Global Patient Registry Software Market was valued at $1089.32 million in 2022, and is projected to reach $2,508.27 million by 2030, growing at a CAGR of 9.7% from 2023 to 2030. Key factors driving the growth of this market include the Government plans to create patient records

Governments from all around the world are attempting to digitize and integrate healthcare systems, such as through creating electronic illness registries, as the need for community health management and health information sharing develops.

Request sample copy of report  The Global Patient Registry Software Market Size, Share & Trends Estimation Report By Registry type Outlook (Disease Registry, Type, Cardiovascular Registry, Diabetes Registry, Cancer Registry, Rare Disease Registry, Others, Health Service Registry, Product Registry, Type, Medical device Registry, Drug Registry), By Software type Outlook (Standalone, Integrated), By End User Outlook(Hospitals, Government and third-party organizations, Pharma, Biotech and Medical Device Companies, Others), By Application Outlook (Government Organizations and Third-party Administrators (TPAs),,Hospitals and Medical Practices, Private Payers, Pharmaceutical, Biotechnology, Medical Device Companies, Research Center), By Functionality Outlook (Population Health Management, Health Information Exchange, Patient Care Management, Medical Research and Clinical Studies, Others)Region and Forecasts, 2023 2030 published by Contrive Datum Insights.

Segmentation Overview:

Type Outlook:

Because its tools were simple to use and had more functionality, independent software generated the greatest revenue in 2019. Standalone software programs are designed to handle a single register, such as details on a patient's diabetes, cancer, unusual disease, heart disease, or other illnesses. So, it is comprehensive and simple to use to gather information. Additionally, standalone's automatic updating capability lowers the price of IT overhead.

End Use Outlook:

The market for patient registry software is segmented by who utilizes it, including government and third parties, hospitals and medical facilities, private payers, pharmaceutical and medical technology firms, and research institutions. Government and outside organizations made the most money in 2019 overall. Because governments in developed and developing nations will utilize this software to decrease the prevalence of diseases, the market for patient registry software is projected to expand over the next years.

Functionality Outlook:

Public health management was the most widely used kind of patient registration software in 2019 based on how well it performed. Because stakeholders demand more options to support value-based care delivery, the fee-for-service (FFS) model has given way to the value-based payment (VBP) model. Another factor driving market growth is PHM's ability to standardize how clinicians treat their patients, enhance clinical outcomes, and reduce the cost of disease treatment.

Regional Analysis:

Geographically, the global Patient Registry Software market has been segmented into, among others, North America, Europe, Asia-Pacific, Latin America, the Middle East, and India. In the near future, this market will be dominated by the global region.Due to the presence of populous nations such as India and China, which will increase the prevalence of chronic diseases, geriatric population, and geriatric population quantity, Asia Pacific is anticipated to post the highest CAGR of 12.1% during the forecast period. Pharmaceutical manufacturing.

North America dominated the global Patient Registry Software market in terms of revenue share in 2019. Increasing disease prevalence and the need for population-based registration are driving regional market expansion.

Buy this Premium Research Report@
https://www.contrivedatuminsights.com/buy/46327

Scope of Report:

Report AttributesDetails
Growth RateCAGR of 9.7% from 2023 to 2030.
Revenue Forecast by 2030$2,508.27 million
By Registry type
  • Disease Registry
  • Type
  • Cardiovascular Registry
  • Diabetes Registry
  • Cancer Registry
  • Rare Disease Registry
  • Others
  • Health Service Registry
  • Product Registry
    • Type
      • Medical device Registry
      • Drug Registry
By Software type  
  • Standalone
  • Integrated
By End User             
  • Hospitals
  • Government and third-party organizations
  • Pharma
  • Biotech and Medical Device Companies
  • Others
By Application
  • Government Organizations and Third-party Administrators (TPAs),
  • Hospitals and Medical Practices
  • Private Payers
  • Pharmaceutical
  • Biotechnology
  • Medical Device Companies
  • Research Center
By Functionality
  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Medical Research and Clinical Studies
  • Others
By Companies
  • IBM Corporation (US)
  • IQVIA Holdings (US)
  • OpenText Corporation (Canada)
  • Optum (US)
  • Premier, Inc. (US)
  • ArborMetrix, Inc. (US)
  • FIGmd (US)
  • McKesson Corporation (US)
  • Syneos Health (US)
  • Dacima Software
  • Inc. (Canada)
  • ifa Systems AG (Germany)
  • Medstreaming- M2S (US)
  • ImageTrend, Inc. (US)
  • Evado Clinical (Australia)
  • WIRB Copernicus Group (US)
  • Global Vision Technologies, Inc. (India)
  • Conduent, Inc. (US)
  • Elekta AB (Sweden)
Regions and Countries Covered
  • North America: (US, Canada, Mexico, Rest of North America)
  • Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
  • The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
  • Latin America(Brazil, Argentina, Rest of Latin America)
  • Rest Of the World
Base Year 2022
Historical Year 2017 to 2022
Forecast Year 2023 to 2030

Market Dynamics:

Restraining Factors:

Privacy and security of Information: Concerns regarding data privacy and security make it more difficult for healthcare organizations to implement patient registry solutions. This is because a data registry compromise could expose the private information of a substantial number of patients.

 Opportunity Analysis:

Numerous individuals utilize the subscription Strategy: The subscription model requires little money up front and simplifies healthcare systems by eliminating the need for IT personnel. This results in increased productivity and decreased costs. This model also permits vendors to license their products and reach prospects and customers in novel and inventive ways.

 Key Segments Covered:

Top Market Players:        

  • IBM Corporation (US) 
  • IQVIA Holdings (US)
  • OpenText Corporation (Canada)
  • Optum (US)
  • Premier, Inc. (US)
  • ArborMetrix, Inc. (US)
  • FIGmd (US)
  • McKesson Corporation (US)
  • Syneos Health (US)
  • Dacima Software
  • Inc. (Canada)
  • ifa Systems AG (Germany)
  • Medstreaming- M2S (US)
  • ImageTrend, Inc. (US)
  • Evado Clinical (Australia)
  • WIRB Copernicus Group (US)
  • Global Vision Technologies, Inc. (India)
  • Conduent, Inc. (US)
  • Elekta AB (Sweden)

 Registry type

  • Disease Registry
  • Type
  • Cardiovascular Registry
  • Diabetes Registry
  • Cancer Registry
  • Rare Disease Registry
  • Others
  • Health Service Registry
  • Product Registry
    • Type
      • Medical device Registry
      • Drug Registry

Software type  

  • Standalone
  • Integrated

End User             

  • Hospitals
  • Government and third-party organizations
  • Pharma
  • Biotech and Medical Device Companies
  • Others

By Application

  • Government Organizations and Third-party Administrators (TPAs),
  • Hospitals and Medical Practices
  • Private Payers
  • Pharmaceutical
  • Biotechnology
  • Medical Device Companies
  • Research Center

Functionality    

  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Medical Research and Clinical Studies
  • Others

 Regions and Countries Covered

  • North America: (US, Canada, Mexico, Rest of North America)
  • Europe: (Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia-Pacific:(Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
  • The Middle East & Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
  • Latin America: (Brazil, Argentina, Rest of Latin America)
  • Rest Of the World

Check out more related studies published by Contrive Datum Insights:

  • Human Machine Interface Market- The global facility management market was valued at $42.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030, reaching a projected value of $59.3 billion by 2030.
  • Facility Management Market- The global facility management market was valued at $42.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030, reaching a projected value of $59.3 billion by 2030.
  • Demand Side Platform Market- The Global Demand Side Platform Market Size Was Valued At USD 16.94 Billion In 2021. The Market Is Projected To Grow From USD 20.77 Billion In 2022 To USD 92.12 Billion By 2029, Exhibiting A CAGR Of 23.7% During The Forecast Period.

Customization of the Report: The report can be customized as per client needs or requirements.For any queries, you can contact us on anna@contrivedatuminsights.com or +1 215-297-4078. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials at various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.

Social: Facebook / LinkedIn / Twitter

Contact Us:
Anna B. | Head Of Sales
Contrive Datum Insights
Phone: +
91 9834816757 | +1 2152974078
Email: 
anna@contrivedatuminsights.com

Website:
https://www.contrivedatuminsights.com
Contrive Datum Insights Press Releases
Latest Contrive Datum Insights Latest Reports